None of them, however, was significantly correlated with the OS—although IgG boosting (n = 10) ( P = .08, HR < 0.01) and the prevaccination CRP level (n = 14) ( P = .18, HR < 0.01) showed a trend of correlation—probably due to the small number of patients tested.
← all excerpts
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.
1
—
—